Skip to content
Longterm Wiki
Index
Grant·Cipig47yYE·Record·Profile

Grant: Icahn School of Medicine at Mount Sinai — COVID-19 Diagnostic Testing (Adolfo García-Sastre) (Coefficient Giving → Icahn School of Medicine at Mount Sinai)

Verdictconfirmed95%
1 check · 4/13/2026

Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Our claim

entire record
Name
Icahn School of Medicine at Mount Sinai — COVID-19 Diagnostic Testing (Adolfo García-Sastre)
Amount
$627,700
Currency
USD
Date
April 2020
Notes
[Scientific Research] Grant Investigators: Chris Somerville and Heather Youngs This page was reviewed but not written by the grant investigators. Icahn School of Medicine at Mount Sinai staff also reviewed this page prior to publication. Open Philanthropy recommended a grant expand[Scientific Research] Grant Investigators: Chris Somerville and Heather Youngs This page was reviewed but not written by the grant investigators. Icahn School of Medicine at Mount Sinai staff also reviewed this page prior to publication. Open Philanthropy recommended a grant of $627,700 to the Icahn School of Medicine at Mount Sinai to support COVID-19 diagnostic testing, led by Professor Adolfo García-Sastre. This funding is intended to support work to test patients for asymptomatic shedding of the virus, conduct serological tests, validate tests, and identify early cellular markers of severe COVID-19 infections. The results of the tests could help inform policies to slow the spread of the virus. This falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.

Source evidence

1 src · 1 check
confirmed95%deterministic-row-match · 4/13/2026
Name
Icahn School of Medicine at Mount Sinai — COVID-19 Diagnostic Testing (Adolfo García-Sastre)
Grantee
Icahn School of Medicine at Mount Sinai
Focus Area
Scientific Research
Amount
$

NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Case № Cipig47yYEFiled 4/13/2026Confidence 95%